Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment

To identify key biomarkers in gemcitabine (GEM)-resistant bladder cancer (BCa) and investigate their associations with tumor-infiltrating immune cells in a tumor immune microenvironment, we performed the present study on the basis of large-scale sequencing data. Expression profiles from the Gene Exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yuxuan, Du, Yiqing, Qin, Caipeng, Liang, Haohong, Yang, Wenbo, Lin, Jiaxing, Ding, Mengting, Han, Jingli, Xu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814447/
https://www.ncbi.nlm.nih.gov/pubmed/35127724
http://dx.doi.org/10.3389/fcell.2021.809620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814447/
https://www.ncbi.nlm.nih.gov/pubmed/35127724
http://dx.doi.org/10.3389/fcell.2021.809620

Ejemplares similares